Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Kiniksa Pharmaceuticals Ltd - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
KNSA
Nasdaq
8731
https://www.kiniksa.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Kiniksa Pharmaceuticals Ltd
Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why
- Mar 4th, 2024 6:23 pm
Does Kiniksa Pharmaceuticals, Ltd. (KNSA) Have the Potential to Rally 32.45% as Wall Street Analysts Expect?
- Mar 1st, 2024 2:55 pm
Kiniksa Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
- Mar 1st, 2024 10:17 am
Chief Medical Officer John Paolini Sells 10,156 Shares of Kiniksa Pharmaceuticals Ltd (KNSA)
- Mar 1st, 2024 4:33 am
Are You Looking for a Top Momentum Pick? Why Kiniksa Pharmaceuticals, Ltd. (KNSA) is a Great Choice
- Feb 29th, 2024 5:00 pm
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 2:21 pm
Kiniksa Pharmaceuticals, Ltd. (KNSA) is on the Move, Here's Why the Trend Could be Sustainable
- Feb 28th, 2024 1:50 pm
Kiniksa Pharmaceuticals, Ltd. (KNSA) Q4 Earnings and Revenues Surpass Estimates
- Feb 28th, 2024 1:40 pm
Kiniksa Pharmaceuticals Ltd (KNSA) Reports Strong Revenue Growth in Q4 and Full-Year 2023
- Feb 28th, 2024 12:52 pm
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution
- Feb 28th, 2024 12:30 pm
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
- Feb 21st, 2024 9:01 pm
Wall Street Analysts Predict a 38.07% Upside in Kiniksa Pharmaceuticals, Ltd. (KNSA): Here's What You Should Know
- Feb 12th, 2024 2:55 pm
How Much Upside is Left in Kiniksa Pharmaceuticals, Ltd. (KNSA)? Wall Street Analysts Think 43.93%
- Jan 23rd, 2024 2:55 pm
Recent Price Trend in Kiniksa Pharmaceuticals, Ltd. (KNSA) is Your Friend, Here's Why
- Jan 23rd, 2024 1:50 pm
Investors in Kiniksa Pharmaceuticals (NASDAQ:KNSA) have seen returns of 30% over the past year
- Jan 15th, 2024 11:14 am
Is Kiniksa Pharmaceuticals (KNSA) Stock a Solid Choice Right Now?
- Jan 9th, 2024 1:46 pm
Kiniksa Pharmaceuticals Provides Corporate Update
- Jan 4th, 2024 12:30 pm
Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference
- Jan 2nd, 2024 9:01 pm
Chief Accounting Officer Michael Megna Sells 9,316 Shares of Kiniksa Pharmaceuticals Ltd (KNSA)
- Dec 23rd, 2023 2:00 pm
The 3 Most Undervalued Biotech Stocks to Buy in December
- Dec 15th, 2023 7:30 pm
Scroll